the aid library

LIST OPTIONS

Filter

11277

Download (399)

View PDF (500)

Global Core Standards for Hospital Anti-microbial Stewardship Programs

Ministry of Public Health, Quatar (2018) C2

International Perspectives and Future Directions

Download (169)

View PDF (221)

Young people and the law in Asia and the Pacific: a review of laws and policies affecting young people's access to sexual and reproductive health and HIV services

UNESCO Office Bangkok and Regional Bureau for Education in Asia and the Pacific United Nations Educational, Scientific and Cultural Education; UNFPA; UNAIDS; UNDP; Youth Lead (2013) C2

Download (258)

View PDF (320)

Child and adolescent mental health policies and plans

Dr M.Funk; M. Belfer; N. Drew; et al. World Health Organization (2005) C_WHO

Mental Health Policy and Service Guidance Package Languages: Arabic, English, French, Chinese, Russian

Download (266)

View PDF (218)

A Guide to Inclusive Education 2023
recommended

Jesuit Refugee Service (2023) CC

Refugee children with disabilities experience a reality of exclusion and marginalisation that makes them among the most vulnerable displaced persons in the world. Excluded from participation in social activities and access to school, not only because of their disability, but especially because of so... more

External Link

Urbanization and mental health: a developing world perspective

Szabo, Christopher, Paul (2018) CC

Current Opinion in Psychiatry: May 2018 - Volume 31 - Issue 3 - p 256–257

External Link

A Is tuberculosis elimination a feasible goal in Colombia by 2050?

López, L.; Y. Keynan, D. Marin et al. (2019) CC

Health Policy and Planning, Volume 35, Issue 1, February 2020, Pages 47–57, https://doi.org/10.1093/heapol/czz122 Colombia has an underreporting of 30% of the total cases, according to World Health Organization (WHO) estimations. In 2016, successful tuberculosis (TB) treatment rate was 70%, and t... more

Download (284)

View PDF (328)

Uso de fármacos antipsicóticos en el tratamiento de la esquizofrenia en niños y adolescentes

Ferrin, M.; H. Gosney; A. Marconi; J. M. Rey IACAPAP (2017) C2

Otros trastornos Capítulo H.5.1 Edición: Matías Irarrázaval & Andres Martin Traductores: Fernanda Prieto-Tagle & Iván Olle Llopis

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (665)

View PDF (677)

Costed Regional Action Plan to End Cross-Border Female Genital Mutilation

UNFPA ESARO UNFPA ESARO (2022) CC

This regional action plan provides a broad framework for the regional level to assist governments in accelerating the implementation of existing international, regional and national commitments on ending FGM. Formulating the plan has provided an opportunity for the region to identify broad prioritie... more

Download (218)

View PDF (255)

IACAPAP Textbook of Child and Adolescent Mental Health - Section D Externalizing disorders

F. D.Zepf T. S. Moriyama; A. J. M. Cho; R. E. Verin; et al. IACAPAP (2012) C2

Externalizing disorders Chapter D.1 Attention deficit hyperactivity disorder

External Link

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials

Kishimoto T., Robenzadeh A, Leucht C, et al. (2014) CC

Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.

Download (156)

View PDF (212)

Ecology and the Common Good: sustainability and Catholic Social Teaching

Butkus, R. A.; S. Kolmes University of Portland Pilot Scholars (2007) C1

There is no question that over the last thirty years environmentaldegradation and the ecological crisis have become in our day and age apredominant sign of the times. In response to this worrisome develop-ment official documents of the Roman Catholic Church, at various lev-els, have sought to addres... more

Download (303)

View PDF (321)

Raport mondial sur le vieillissement et la santé

Organisation mondiale de la Santé (2016) C_WHO

Catalogage à la source : Bibliothèque de l’OMS Rapport mondial sur le vieillissement et la santé. 1.Vieillissement. 2.Espérance de vie. 3.Sujet âgé. 4.Services de santé pour personnes âgées. 5.Santé mondiale. 6.Dynamique des populations. 7.Prestations des soins de santé. I.Organisation... more

Download (152)

View PDF (184)

The Development Impact of the War in Ukraine: Initial projections

UNDP (2022) C1

Early data estimates suggest that 90% of the Ukrainian population could be facing poverty and extreme economic vulnerability should the war deepen, setting the country – and the region – back decades and leaving deep social and economic scars for generations to come

Download (653)

View PDF (1376)

Liberia: Investment Plan for Building a Resilient Health System 2015-2021

Ministry of Health, Government of Liberia (2015) C1

Download (1025)

View PDF (2091)

Gender-Age Marker Toolkit

European Commission Humanitarian Aid and Civil Protection (2010)

Download (307)

View PDF (422)

Global Health Security (GHS) Index

Nuclear Threat Initiative (NTI) and the Johns Hopkins Center for Health Security (JHU) The Economist Intelligence Unit (EIU) (2019) CC

The GHS Index is intended to be a key resource in the face of increasing risks of high-consequence and globally catastrophic biological events and in light of major gaps in international financing for preparedness. These risks are magnified by a rapidly changing and interconnected world; increasing ... more